Edwards Lifesciences Corp. Stock Underperforms Thursday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Edwards Lifesciences Corp. (EW) shares fell 2.65% to $89.83 on Thursday, underperforming the broader market and snapping a two-day winning streak. The decline occurred during a grim trading session where the S&P 500 dropped 0.87% and the Dow Jones Industrial Average fell 1.32%. Edwards closed 6.71% below its 52-week high of $96.29. Compared to competitors, Abbott Laboratories fell 0.25%, Medtronic declined 1.94%, and Stryker dropped 3.61%.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Edwards Lifesciences Corp. (EW) shed 2.65% to $89.83 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.87% to 7,641.16 and Dow Jones Industrial Average falling 1.32% to 52,759.21.
The stock's fall snapped a two-day winning streak.
Edwards Lifesciences Corp. closed 6.71% below its 52-week high of $96.29, which the company reached on July 7th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Abbott Laboratories (ABT) fell 0.25% to $114.14, Medtronic PLC (MDT) fell 1.94% to $92.30, and Stryker Corp. (SYK) fell 3.61% to $327.70.
Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-20-26 1650ET